National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 8) – specification under subsection 84AAA(2) (PB 92 of 2014) (Cth)

PB 92 of 2014

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 8) – specification under subsection 84AAA(2)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 25 November 2014

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 8) – specification under subsection 84AAA(2).

(2)This Instrument may also be cited as PB 92 of 2014.

2          Commencement

This Instrument commences on 1 December 2014.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1        Amendments

1. Schedule 1, after entry for Enalapril with Hydrochlorothiazide

insert:

Enzalutamide Capsule 40 mg Oral 112 2

1. Schedule 1, after entry for Triptorelin

insert:

Umeclidinium	Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses	Inhalation by mouth	1	5
Umeclidinium with vilanterol	Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses	Inhalation by mouth	1	5